iTeos Therapeutics Closes $125 Million Series B2 Financing

Cambridge, MA and Gosselies, Belgium – April 1 (Korea Bizwire) – iTeos Therapeutics Inc., a privately-held clinical-stage biotechnology company developing innovative cancer immunotherapies, announced today the closing of an oversubscribed Series B2 financing, which raised a total of $125 million. The Series B2 financing round was co-led by RA Capital Management and Boxer Capital, and [...]